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summary 
Erythrocyte acid phosphatase (ACP,) phenotype was examined in 3001 
Caucasian infants born at the University of Michigan Women’s Hospital. 
Contrary to reports from other studies, there was no relationship between the 
ACP, phenotype and risk of preterm birth in either the total sample or when 
the sample was subdivided by sex of infant. 
gestational age; preterm birth; marker; erythrocyte acid phosphatase 
In Caucasians, the erythrocyte acid phosphatase ACP, polymorphism is 
determined by three common alleles (Pa, Pb, PC) at an autosomal locus. There 
are thus six electrophoretic phenotypes with a spectrum of enzymatic activity 
and physical and kinetic properties [l-5]. ACP, is suggested to have a 
physiological function as a flavin mononucleotide phosphatase and as such 
could have a role in regulating the levels of erythrocyte reduced glutathione 
and maintenance of erythrocyte integrity [6]. Bottini and coworkers have 
previously reported an association of gestational length and ACP, phenotype in 
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TABLE I 
Rate of preterm birth by ACP, phenotype in University of Michigan and Rome samples. 
ACP, phenotype 
AA BB CC AB AC BC All 
University of Michigan 
% preterm births 
(Total No. with phenotype) 
Rome 
% of preterm births 
(Total No. with phenotype) 
10.3 11.9 12.5 11.2 12.4 8.8 11.3 
(331) (1197) (8) (1228) (89) (148) (3001) 
11.7 6.7 4.7 11.8 3.6 6.4 
(60) (282) Fl) (192) (17) (56) (608) 
a group of newborns studied at the University of Rome [7,8]. A sample of 608 
infants was classified by ACP, phenotype and by whether they were “preterm” 
(gestational length less than 37 weeks) [7]. The proportion of preterm births was 
higher in infants without the Pb allele than in infants with the Pb allele. When 
infants were stratified by sex, the relationship was apparent only in males. 
Bottini hypothesized that the ACP, phenotype plays a role in determining 
gestational length in males and that the rate of preterm birth is lowest with a 
single dose of the Pb allele. In the present study, we explore these hypotheses in 
a sample of 3001 infants. 
The sample of 3001 Caucasian live births consisted of infants born at the 
University of Michigan Women’s Hospital maternity service whose parents 
agreed to donate blood samples for another study [9]. Laboratory methods and 
allele frequencies for ACP, and for 50 additional loci have been described else- 
where [lo]. Hospital records of the infants were used to obtain gestational 
length, maternal age, race, presence of diabetes and smoking habit during preg- 
nancy. Preterm status was taken as less than 37 weeks gestational length to 
agree with Bottini’s definition. The x2 test was used, with statistical significance 
taken to be a P-value of 0.05 or less. 
Table I shows the percentage of preterm births by ACP, phenotype in the 
University of Michigan and Rome samples. In the Michigan sample, 10.8% of 
infants without the Pb allele were preterm, compared to 11.4% of infants with 
the Pb allele. When the sample was stratified by sex, the percentage of preterm 
births remained independent of the presence of the Pb allele (Table II). In the 
Rome sample, however, 11.5% of infants without the Pb allele were preterm, 
compared to only 5.7% of infants with the Pb allele (x2 = 3.914, d.f. = 1, 
P < 0.05). The discrepancy was apparent only in male infants (Table II). 
We asked if the difference in the results of the Michigan study from those of 
Bottini in Rome could be due to environmental influences. For example, 
perhaps mothers in this sample who carried the Pb allele were more likely to be 
very young and hence more likely to deliver a preterm infant. There was no 
relation between allelic type and the maternal characteristics for which data 
were available (maternal age, smoking, or presence of diabetes), so these varia- 
bles could not have influenced the result. 
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TABLE II 
Rate of preterm birth by dose of Pb allele and sex of infant. 
Dose of Pb*.** 
0 1 2 All 
University of Michigan 
% preterm births 
(Total No. in group) 
Rome 
% preterm births 
(Total No. in group) 
Females 
University of Michigan 
% preterm births 
(Total No. in group) 
Rome 
% preterm births 




























*0 = AA,AC,CC;l = AB,BC;Z = BB. 
??* Sex missing for 49 infants in University of Michigan sample. 
The discrepancy in the results of the two studies may be due to significant 
differences in the two populations sampled. In the Rome sample, the rate of 
preterm birth is 6.4% compared to 11.3% in the University of Michigan sample 
or’ = 12.849, d.f. = 1, P < 0.001). The University of Michigan hospital is a 
tertiary care center, so the higher preterm birth rate probably reflects the short 
gestation associated with problem pregnancies that are referred there. The dif- 
ferential in sample rates of preterm birth is consistent in both sexes (Table II). 
There was also a significant difference in the distribution of the ACP, 
phenotype in female infants in the two samples (Table II). In the University of 
Michigan sample, 39.5% of the females were homozygous for allele Pb, while 
45.1% were heterozygous for the Pb allele. The relationship was reversed in the 
Roman sample (47.7% and 38.8%, respectively; x2 = 6.422, d.f. = 2, P < 
0.05 for comparison by dose of Pb allele in the two samples). However, the dif- 
ference in phenotype distribution could not be responsible for the observed dif- 
ferential in preterm birth rates in the two samples, since the rate in both was 
consistent across phenotypes for females in both samples. There was no 
statistically significant difference in the male phenotype frequencies of the two 
samples. 
Gene frequencies in the two samples can be determined from data in Table I. 
The frequency of the Pa allele is 0.33 in Michigan but only 0.27 in Rome, while 
the frequency of the Pb allele is higher in Rome (0.67 vs. 0.63). The difference 
in gene frequencies in the two samples is statistically significant (x2 = 22.055, 
d.f. = 2, P < 0.001) The University of Michigan sample appears to be in 
Hardy-Weinberg equilibrium, while the Rome sample does not (x2 = 11.298, 
d.f. = 5, P < 0.05 for comparison of observed and expected phenotypes). 
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The differing rates of preterm birth, gene frequency and phenotype distribution 
in the two studies suggest that the populations are not comparable, and that there 
are other factors that influence gestational length independent of, or in concert with, 
ACP, phenotype. For example, the Michigan population is almost devoid of glu- 
cose-6-phosphate dehydrogenase (G6PD) deficiency. In a subset of this sample, only 
three of 908 male newborns had marginal G6PD deficiency (activity 1%25% of 
normal) [ 111. The level of ACP, activity (and therefore genotype) has been reported 
to be inversely related to the erythrocyte concentration of the enzyme cofactor, 
flavin adenine dinucleotide (FAD) and, therefore, the basal activity of the key ery- 
throcyte enzyme, glutathione reductase. Increased ingestion of the vitamin 
riboflavin, the precursor for FAD, would undoubtedly tend to diminish the role of 
ACP, in the regulation of glutathione reductase activity, reduced glutathione levels 
and erythrocyte integrity. The large size of our sample, however, leaves little doubt 
that ACP, phenotype is unrelated to gestational length in the University of Michigan 
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